Viracta Therapeutics, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Viracta Therapeutics, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2011 to Q4 2023.
  • Viracta Therapeutics, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $6.78M, a 17.3% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $6.78M +$998K +17.3% Dec 31, 2023 10-K 2024-03-07
Q4 2022 $5.78M +$819K +16.5% Dec 31, 2022 10-K 2024-03-07
Q4 2021 $4.96M +$991K +25% Dec 31, 2021 10-K 2024-03-07
Q4 2020 $3.97M +$2.02M +103% Dec 31, 2020 10-K 2023-03-14
Q4 2019 $1.95M +$397K +25.5% Dec 31, 2019 10-K 2022-03-17
Q4 2018 $1.56M -$214K -12.1% Dec 31, 2018 8-K/A 2021-03-23
Q4 2017 $1.77M +$328K +22.8% Dec 31, 2017 10-K 2020-03-10
Q4 2016 $1.44M +$60K +4.35% Dec 31, 2016 10-K 2019-03-07
Q4 2015 $1.38M +$1.38M Dec 31, 2015 10-K 2018-03-09
Q4 2014 $0 $0 Dec 31, 2014 10-K 2017-03-09
Q4 2013 $0 $0 Dec 31, 2013 10-K 2015-03-12
Q4 2012 $0 $0 Dec 31, 2012 10-K 2014-03-06
Q4 2011 $0 Dec 31, 2011 10-K 2013-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.